Urinary tract infection
Urinary tract infection (UTI) refers to the inflammation caused by the growth and reproduction of pathogens in the urinary tract and the invasion of the urinary tract mucosa or tissue. It is the most common type of bacterial infection. Urinary tract infection is divided into upper urinary tract infection and lower urinary tract infection. Upper urinary tract infection refers to pyelonephritis, and lower urinary tract infection includes urethritis and cystitis. According to the presence or absence of underlying diseases, urinary tract infection can also be divided into complicated urinary infection and uncomplicated urinary infection. Pyelonephritis is further divided into acute pyelonephritis and chronic pyelonephritis. It is more common in women. Its clinical manifestations are often: acute urethral syndrome, chronic urethral syndrome, asymptomatic bacteriuria, renal abscess and perinephric abscess. Among them, urinary tract infections caused by different pathogens include: chlamydial urinary tract infection, mycoplasma urinary tract infection, fungal urinary tract infection, and parasitic urinary tract infection. Urinary tract infections in different populations include: menopausal urinary tract infection, pediatric urinary tract infection, elderly urinary tract infection, postpartum urinary tract infection, and pregnancy urinary tract infection.
-
Site of disease:
Penile urethra -
Infectious :
Not contagious -
Frequent population:
Women of childbearing age and postmenopausal women, diabetes... -
Related symptoms:
Complicated urinary tract infection renal abscess repeated urinary tract infection turbid urine true bacteriuria -
Concurrent disease:
Related Drugs
Ceftriaxone Sodium for Injection
Indication: It is suitable for pneumonia and other lower respiratory tract infections, urinary tract infections, meningitis, sepsis, abdominal infections, pelvic infections, skin and soft tissue infections, reproductive tract infections, bone and joint infections caused by sensitive bacteria. Cefotaxime can be used as a drug of choice for infantile meningitis.
Manufacturer:
Sichuan Pharmaceutical, Inc.
Ciprofloxacin Lactate for Injection
Indication: Intended for infections caused by sensitive bacteria: 1. Urinary and reproductive system infections, including simple and complicated urinary tract infections, bacterial prostatitis, urethritis or cervicitis caused by Neisseria gonorrhoeae (including those caused by enzyme-producing strains); 2. Respiratory tract infections, including acute attacks of bronchial infections and lung infections caused by sensitive Gram-negative bacilli; 3. Gastrointestinal infections caused by Shigella, Salmonella, enterotoxigenic Escherichia coli, Aeromonas hydrophila, Vibrio parahaemolyticus, etc.; 4. Typhoid fever; 5. Bone and joint infections; 6. Skin and soft tissue infections; 7. Systemic infections such as sepsis.
Cephalexin Granules
Indication: It is suitable for acute tonsillitis, pharyngitis, otitis media, sinusitis, bronchitis, pneumonia and other respiratory tract infections, urinary tract infections and skin and soft tissue infections caused by sensitive bacteria. This product is an oral preparation and should not be used for severe infections.
Manufacturer:
Hebei Huaweiman Pharmaceutical Co., Ltd.
Children's compound sulfamethoxazole tablets
Indication: In recent years, many common clinical pathogens often show resistance to this product, so the treatment of bacterial infections needs to refer to the drug sensitivity results. The main indications of this product are the following infections caused by sensitive strains: 1. Urinary tract infections caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella. 2. Acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae. 3. Acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae. 4. Intestinal infections and Shigella infections caused by sensitive strains of Shigella flexneri or sonnei. 5. This product is the first choice for the treatment of Pneumocystis carinii pneumonia. 6. For the prevention of Pneumocystis carinii pneumonia, patients with a history of at least one attack of Pneumocystis carinii disease or HIV-infected adults can use it, whose CD4 lymphocyte count is ≤200/mm3 or less than 20% of the total lymphocyte count. 7. Traveler's diarrhea caused by enterotoxigenic Escherichia coli (ETEC).
Manufacturer:
Gansu Lanyao Pharmaceutical Co., Ltd.
Children's compound sulfamethoxazole tablets
Indication: In recent years, many common clinical pathogens often show resistance to this product, so the treatment of bacterial infections needs to refer to the drug sensitivity results. The main indications of this product are the following infections caused by sensitive strains: 1. Urinary tract infections caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella. 2. Acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae. 3. Acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae. 4. Intestinal infections and Shigella infections caused by sensitive strains of Shigella flexneri or sonnei. 5. This product is the first choice for the treatment of Pneumocystis carinii pneumonia. 6. For the prevention of Pneumocystis carinii pneumonia, patients with a history of at least one attack of Pneumocystis carinii disease or HIV-infected adults can use it, whose CD4 lymphocyte count is ≤200/mm3 or less than 20% of the total lymphocyte count. 7. Traveler's diarrhea caused by enterotoxigenic Escherichia coli (ETEC).
Manufacturer:
Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd.
Children's compound sulfamethoxazole tablets
Indication: In recent years, many common clinical pathogens often show resistance to this product, so the treatment of bacterial infections needs to refer to the drug sensitivity results. The main indications of this product are the following infections caused by sensitive strains: 1. Urinary tract infections caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella. 2. Acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae. 3. Acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae. 4. Intestinal infections and Shigella infections caused by sensitive strains of Shigella flexneri or sonnei. 5. This product is the first choice for the treatment of Pneumocystis carinii pneumonia. 6. For the prevention of Pneumocystis carinii pneumonia, patients with a history of at least one attack of Pneumocystis carinii disease or HIV-infected adults can use it, whose CD4 lymphocyte count is ≤200/mm3 or less than 20% of the total lymphocyte count. 7. Traveler's diarrhea caused by enterotoxigenic Escherichia coli (ETEC).
Manufacturer:
Gansu Zhijiao Pharmaceutical Co., Ltd.
Children's compound sulfamethoxazole tablets
Indication: In recent years, many common clinical pathogens often show resistance to this product, so the treatment of bacterial infections needs to refer to the drug sensitivity results. The main indications of this product are the following infections caused by sensitive strains: 1. Urinary tract infections caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella. 2. Acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae. 3. Acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae. 4. Intestinal infections and Shigella infections caused by sensitive strains of Shigella flexneri or sonnei. 5. This product is the first choice for the treatment of Pneumocystis carinii pneumonia. 6. For the prevention of Pneumocystis carinii pneumonia, patients with a history of at least one attack of Pneumocystis carinii disease or HIV-infected adults can use it, whose CD4 lymphocyte count is ≤200/mm3 or less than 20% of the total lymphocyte count. 7. Traveler's diarrhea caused by enterotoxigenic Escherichia coli (ETEC).
Manufacturer:
Gansu Zhijiao Pharmaceutical Co., Ltd.
Children's compound sulfamethoxazole tablets
Indication: In recent years, many common clinical pathogens often show resistance to this product, so the treatment of bacterial infections needs to refer to the drug sensitivity results. The main indications of this product are the following infections caused by sensitive strains: 1. Urinary tract infections caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella. 2. Acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae. 3. Acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae. 4. Intestinal infections and Shigella infections caused by sensitive strains of Shigella flexneri or sonnei. 5. This product is the first choice for the treatment of Pneumocystis carinii pneumonia. 6. For the prevention of Pneumocystis carinii pneumonia, patients with a history of at least one attack of Pneumocystis carinii disease or HIV-infected adults can use it, whose CD4 lymphocyte count is ≤200/mm3 or less than 20% of the total lymphocyte count. 7. Traveler's diarrhea caused by enterotoxigenic Escherichia coli (ETEC).
Manufacturer:
GuangDongBangMinPharmaceutical Co., Ltd.
Children's compound sulfamethoxazole tablets
Indication: In recent years, many common clinical pathogens often show resistance to this product, so the treatment of bacterial infections needs to refer to the drug sensitivity results. The main indications of this product are the following infections caused by sensitive strains: 1. Urinary tract infections caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella. 2. Acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae. 3. Acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae. 4. Intestinal infections and Shigella infections caused by sensitive strains of Shigella flexneri or sonnei. 5. This product is the first choice for the treatment of Pneumocystis carinii pneumonia. 6. For the prevention of Pneumocystis carinii pneumonia, patients with a history of at least one attack of Pneumocystis carinii disease or HIV-infected adults can use it, whose CD4 lymphocyte count is ≤200/mm3 or less than 20% of the total lymphocyte count. 7. Traveler's diarrhea caused by enterotoxigenic Escherichia coli (ETEC).
Manufacturer:
Guangdong Nanguo Pharmaceutical Co., Ltd.
Children's compound sulfamethoxazole tablets
Indication: In recent years, many common clinical pathogens often show resistance to this product, so the treatment of bacterial infections needs to refer to the drug sensitivity results. The main indications of this product are the following infections caused by sensitive strains: 1. Urinary tract infections caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella. 2. Acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae. 3. Acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae. 4. Intestinal infections and Shigella infections caused by sensitive strains of Shigella flexneri or sonnei. 5. This product is the first choice for the treatment of Pneumocystis carinii pneumonia. 6. For the prevention of Pneumocystis carinii pneumonia, patients with a history of at least one attack of Pneumocystis carinii disease or HIV-infected adults can use it, whose CD4 lymphocyte count is ≤200/mm3 or less than 20% of the total lymphocyte count. 7. Traveler's diarrhea caused by enterotoxigenic Escherichia coli (ETEC).